Nordic Capital Invests in eResearch Technology,Inc.

We represented Nordic Capital Fund VIII (Nordic Capital) as special healthcare counsel in its definitive agreement to become the new controlling shareholder of U.S. – based company eResearch Technology, Inc. (ERT). Terms of the transaction were not disclosed.

Nordic Capital Funds invest in companies in northern Europe and in selected investment opportunities internationally. Nordic Capital Fund VIII has EUR 3.5 billion in committed capital, principally provided by international institutional investors such as pension funds. ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development.

You Also May Be Interested In:

  • Representation of Triage Consulting Group, a healthcare revenue integrity company in its acquisition by Revint Solutions, a leader in technology-enabled revenue integrity solutions for healthcare providers

    We represented Triage Consulting Group, a healthcare revenue integrity company in its acquisition by Revint Solutions, a leader in technology-enabled...
    Client Type: Private Company
  • Representation of Twin River Worldwide Holdings, Inc. (NYSE: TRWH) in its definitive agreement to acquire Jumer’s Casino & Hotel, from Delaware North Companies Gaming & Entertainment, Inc., for $120 million in cash

     

    We represented Twin River Worldwide Holdings, Inc. in its definitive agreement to acquire Jumer's Casino & Hotel, from Delaware North...
    Client Type: Public Company
  • Representation of Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by Shore Capital Partners, in its affiliation with Atlanta Allergy & Asthma, the largest allergy practice in Georgia

    We represented Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by...
    Client Type: Private Company